David Charytan

Director, Division of Nephrology · NYU Grossman School of Medicine

Credentials: · · · ·

History

Deep Learning on ECGs to Improve Outcomes in Patients on Dialysis
National Heart, Lung, and Blood Institute · R01
PI · $2.9M · Icahn School of Medicine at Mount Sinai
2023–2028
Safety and Efficacy of Empagliflozin Main Intenance HD (SEED)
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1M · New York University School of Medicine
2023–2027
Intradialytic Myocardial Stunning in Hemodialysis Patients - A Novel Cardiovascular Risk Factor
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.5M · New York University School of Medicine
2021–2026
Pain, Opioids, and ESRD Risk Reduction with Mindfulness and Buprenorphine (POEM-B): A 3-Arm Multi-Site Randomized Trial in Hemodialysis Patients
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $2.9M · New York University School of Medicine
2019–2024

Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease
Principal investigator · Not yet recruiting
NYU Langone Health
2027
Safety and Efficacy of Empagliflozin in Hemodialysis
Principal investigator · Recruiting · Phase 2
NYU Langone Health
2024–2026
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
Principal investigator · Recruiting
NYU Langone Health
2023–2026
Evolocumab In Advanced Chronic Kidney Disease Trial
Principal investigator · Withdrawn · Phase 4
NYU Langone Health
2021